Open Access

Successful and long‑term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2‑positive extramammary Paget's disease: A case report and review of the literature

  • Authors:
    • Takashi Ichiyama
    • Daisuke Gomi
    • Toshirou Fukushima
    • Takashi Kobayashi
    • Nodoka Sekiguchi
    • Akiyuki Sakamoto
    • Shigeru Sasaki
    • Keiko Mamiya
    • Tomonobu Koizumi
    • Yoshihisa Hama
  • View Affiliations

  • Published online on: September 19, 2017     https://doi.org/10.3892/mco.2017.1422
  • Pages: 763-766
  • Copyright: © Ichiyama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A 58‑year‑old woman with a histologically confirmed diagnosis of vulvar extramammary Paget's disease (EMPD) was referred to our hospital due to locally advanced and relapsed EMPD. The patient had undergone surgical resection three times for relapsed vulvar EMPD over a period of 12 years, but developed locally advanced and unresectable EMPD. As pathological examination indicated that the lesion was positive for human epidermal growth factor receptor 2 (HER2) on immunohistochemical staining, the patient was treated with trastuzumab plus paclitaxel. The primary tumor mass and lymph node metastasis regressed successfully with combined trastuzumab and paclitaxel therapy, and the disease has been stable for >2 years after the initiation of treatment. These observations suggest that HER2 status must be determined in patients with advanced and/or metastatic extramammary Paget's disease and therapy with HER2 inhibitors should be considered as an option for the treatment of HER2‑positive EMPD.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 7 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ichiyama T, Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Sakamoto A, Sasaki S, Mamiya K, Koizumi T, Hama Y, Hama Y, et al: Successful and long‑term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2‑positive extramammary Paget's disease: A case report and review of the literature. Mol Clin Oncol 7: 763-766, 2017
APA
Ichiyama, T., Gomi, D., Fukushima, T., Kobayashi, T., Sekiguchi, N., Sakamoto, A. ... Hama, Y. (2017). Successful and long‑term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2‑positive extramammary Paget's disease: A case report and review of the literature. Molecular and Clinical Oncology, 7, 763-766. https://doi.org/10.3892/mco.2017.1422
MLA
Ichiyama, T., Gomi, D., Fukushima, T., Kobayashi, T., Sekiguchi, N., Sakamoto, A., Sasaki, S., Mamiya, K., Koizumi, T., Hama, Y."Successful and long‑term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2‑positive extramammary Paget's disease: A case report and review of the literature". Molecular and Clinical Oncology 7.5 (2017): 763-766.
Chicago
Ichiyama, T., Gomi, D., Fukushima, T., Kobayashi, T., Sekiguchi, N., Sakamoto, A., Sasaki, S., Mamiya, K., Koizumi, T., Hama, Y."Successful and long‑term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2‑positive extramammary Paget's disease: A case report and review of the literature". Molecular and Clinical Oncology 7, no. 5 (2017): 763-766. https://doi.org/10.3892/mco.2017.1422